Literature DB >> 589161

Allopurinol treatment for calcium stone disease.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 589161      PMCID: PMC1632591          DOI: 10.1136/bmj.2.6098.1302-a

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  7 in total

Review 1.  Hypercalciuria and hyperuricosuria in patients with calcium nephrolithiasis.

Authors:  F L Coe; A G Kavalach
Journal:  N Engl J Med       Date:  1974-12-19       Impact factor: 91.245

2.  The effect of oral sodium phosphate on the formation of renal calculi and on idiopathic hypercalcuria.

Authors:  D S Bernstein; R Newton
Journal:  Lancet       Date:  1966-11-19       Impact factor: 79.321

3.  Allopurinol treatment of uric-acid disorders in calcium-stone formers.

Authors:  F L Coe; L Raisen
Journal:  Lancet       Date:  1973-01-20       Impact factor: 79.321

4.  Epitaxy as a growth factor in urinary calculi and gallstones.

Authors:  K Lonsdale
Journal:  Nature       Date:  1968-01-06       Impact factor: 49.962

5.  Calcium oxalate crystalluria and urine saturation in recurrent renal stone-formers.

Authors:  W G Robertson; M Peacock; B E Nordin
Journal:  Clin Sci       Date:  1971-05       Impact factor: 6.124

6.  Saturation-inhibition index as a measure of the risk of calcium oxalate stone formation in the urinary tract.

Authors:  W G Robertson; M Peacock; R W Marshall; D H Marshall; B E Nordin
Journal:  N Engl J Med       Date:  1976-01-29       Impact factor: 91.245

7.  Renal calculi.

Authors:  E R Yendt
Journal:  Can Med Assoc J       Date:  1970-03-14       Impact factor: 8.262

  7 in total
  1 in total

1.  Effects of sodium urate and uric acid crystals on the crystallization of calcium oxalate.

Authors:  H G Tiselius
Journal:  Urol Res       Date:  1984
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.